Implementing Digital Technologies in Clinical Trials: Lessons Learned.
Multiple digital health technologies have been evaluated across clinical development programs, including external, wearable, implantable, and ingestible devices and sensors, along with digital mobile health applications (apps) that are accessible via users' personal electronic devices (e.g., smartph...
| Publicado en: | Innovations in Clinical Neuroscience Vol. 19; no. 4-6; pp. 65 - 70 |
|---|---|
| Autores principales: | , , , , , , |
| Formato: | review tables/charts Journal Article |
| Publicado: |
Matrix Medical Communications, LLC
Apr-Jun2022
|
| Acceso en línea: | Ver este registro en EBSCOhost |
| fields | @attributes: recordID: 1 pdfLink: plink: https://search.ebscohost.com/login.aspx?direct=true&db=ccm&AN=157828218&site=ehost-live header: @attributes: shortDbName: ccm uiTerm: 157828218 longDbName: CINAHL Complete uiTag: AN controlInfo: bkinfo: dissinfo: jinfo: jid: 21588333 DAD5 jtl: Innovations in Clinical Neuroscience issn: 21588333 maglogo: N pubinfo: dt: Apr-Jun2022 vid: 19 iid: 4-6 pid: 33670 pub: Matrix Medical Communications, LLC place: West Chester, Pennsylvania artinfo: ui: 157828218 157828218 157828218 157828218 ppf: 65 ppct: 5 formats: fmt: @attributes: type: P tig: atl: Implementing Digital Technologies in Clinical Trials: Lessons Learned. aug: au: MITSI, GEORGIA GRINNELL, TODD GIORDANO, SUZANNE GOODIN, THOMAS SANJAR, SHAHIN MARBLE, ELIZABETH PIKALOV, ANDREI affil: Sunovion Pharmaceuticals Inc. in Marlborough, Massachusetts sug: subj: Digital Technology Utilization Clinical Trials Mobile Applications Telehealth Patient Access to Records Machine Learning Wearable Sensors Smartphone Diffusion of Innovation ab: Multiple digital health technologies have been evaluated across clinical development programs, including external, wearable, implantable, and ingestible devices and sensors, along with digital mobile health applications (apps) that are accessible via users' personal electronic devices (e.g., smartphones, tablets, and computers). Several of these technologies have been incorporated into our ongoing neurology and respiratory clinical development programs. Based on our experience, one of the greatest potential benefits of digital health technologies is the ability to collect objective and/or biological data continuously or at regular intervals outside of office visits during a patient's normal daily activities to provide additional efficacy and safety information, versus data capture from traditional episodic, time point-based office visits. Many challenges encountered with digital health technologies can be successfully addressed by providing the appropriate training to staff and patients, ensuring availability of appropriate infrastructure support, and conducting pilot studies before scaling up to larger trials. Overall, our experience with digital health technologies demonstrated their potential to increase the amount of objective data collected in clinical trials, expand patient access to trials, and facilitate further improvement of clinical outcomes. pubtype: Academic Journal doctype: review tables/charts Journal Article ougenre: Article language: English refInfo: holdings: @attributes: islocal: N |
|---|